Implementation of a center for drug policy across a system of hospitals

Klinger, Elissa V.; Yu-Chen Yeh; Churchill, William; Clapp, Margaret; Reddy, Prabashni
May 2010
American Journal of Health-System Pharmacy;5/1/2010, Vol. 67 Issue 9, p702
Academic Journal
The article discusses the creation and implementation of the Center for Drug Policy (CDP) at Partners Healthcare System Inc. (PHS) in New England. It notes that CDP was developed in August 2007 to predict and manage high-cost medications by streamlining the enforcement of PHS' prescribing guidelines. It tracks the biological agents and emerging drugs through various sources. It cooperates with the working group for the guidelines communication and implementation.


Related Articles

  • Drug abuse: It's killing us. Posey, L. Michael // Pharmacy Today;Jun2010, Vol. 16 Issue 6, p5 

    In this article, the author discusses drug abuse problem in the U.S. and the shift in the drug-control policy which calls for balance among prevention, treatment, and law enforcement. He points out on street drugs which are aspects of drug abuse and the negative effects of drug abuse on the...

  • OTHER VOICES.  // Modern Healthcare;5/24/2010, Vol. 40 Issue 21, p20 

    The article presents quotes on anti-drug policy in the U.S. from the "Christian Science Monitor" and "New York Times."

  • Mandatory Use of Prescription Drug Monitoring Programs. Haffajee, Rebecca L.; Jena, Anupam B.; Weiner, Scott G. // JAMA: Journal of the American Medical Association;3/3/2015, Vol. 313 Issue 9, p891 

    The authors assess the effectiveness of prescription drug monitoring programs (PDMP) in the U.S. in controlling prescription drug overdose and abuse. They discuss the reasons behind some physicians' opposition of PDMPs, the rate of opioid overdose in the country as of 2011 and the percentage of...

  • The Other War's Casualties: Drug War's Innocent Victims. BUELL, JOHN // Progressive Populist;11/15/2014, Vol. 20 Issue 20, p16 

    The article discusses issues over the war on drugs in the U.S. as of November 2014. Topics covered include the association of sentencing policies with the growth in incarceration for drug offenders, according to a report by nonprofit organization The Sentencing Project, the role of increases in...

  • NACDS RxImpact Day consults new Congress. Alexander, Antoinette // Drug Store News;2/28/2011, Vol. 33 Issue 3, p10 

    The article provides information on the NACDS RxImpact Day to be held on March 8-9, 2011 in Washington. The goal of the event is to inform lawmakers about the significant role played by retail pharmacy in the country's healthcare system. The focus will be on Medicaid AMP-based pricing. Debbie...

  • Drug Policy: Guide to Critical Analysis.  // Points of View: Drug Policy;2017, p4 

    This article offers a critical guide to the controversial issue of drug policy in the U.S. The article discusses criteria in understanding the issue, such as distinguishing between fact and opinion and recognizing point and counterpoint arguments. Also presented are exercises that help the...

  • Savings from biosimilars won't compare to today's generics. Edlin, Mari // Managed Healthcare Executive;Apr2010, Vol. 20 Issue 4, p21 

    The article focuses on benefits of the adoption of follow-on biologics (FOBs) or biosimilars in the U.S. One challenge of the adoption of biosimilars is that they require a different approval pathway than the Food and Drug Administration (FDA) applies to generics. It is estimated by the...

  • Recent Issues Regarding Controlled Substances. Helgeland, Dave // South Dakota Medicine;Mar2013, Vol. 66 Issue 3, p105 

    The article discusses developments in regulatory interpretations, policies and potential regulations related to controlled substances in the U.S. Prescriptions for Schedule II drugs (C-II) should be written and signed by the prescriber. Physician assistants, certified nurse practitioners and...

  • Counterpoint: The War on Drugs is a Losing Battle. Issitt, Micah; Finley, Laura // Points of View: Drug Policy;2017, p3 

    The article presents an argument against the U.S. drug policy. It is suggested that criminal penalties for drug use and possession represent a waste of public money and are an ineffective strategy for reducing the drug supply and prevention of illegal drug use. A background of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics